Aldevron Breakthrough Blog

cssDNA as a Nex-Generation Genetic Payload Platform

October 21, 2026 by Tyler Kozisek

Structure Drives Function in DNA Delivery

One of the most compelling emerging themes in genetic medicine is that DNA structure—not just sequence—fundamentally impacts delivery and editing outcomes. Circular single-stranded DNA (cssDNA) is gaining attention as a next-generation payload format designed to overcome key limitations of traditional double-stranded DNA donors. The main advantages are that circular single-stranded DNA improves delivery, supports larger edits, and expands the future of gene therapy payload design.

Why dsDNA Falls Short
Traditional dsDNA donors introduce several challenges, such as:

These issues become more pronounced with larger payloads, in vivo delivery and complex engineering applications.


Advantages of cssDNA

cssDNA offers several key advantages over dsDNA:

Critically, cssDNA also enables efficient handling of large genetic payloads without sacrificing delivery performance.

Enabling Large and Complex Edits

When reviewing data about cssDNA, we find several important points, including:

Because of this information, cssDNA is positioned as a key enabler of multi-gene constructs, logic-based gene circuits and advanced CAR designs

Synergy with Delivery Platforms

A question is how well cssDNA can perform in regard to delivery. It’s been found to pair effectively with:

The strongest benefits were observed when payload size increased and nuclear access became rate-limiting.

Beyond Integration: Toward Safer Editing

Importantly, cssDNA supports:

This aligns with industry trends toward reduced genotoxic risk, re-dosable therapies, and transient (yet functional) interventions.

The Takeaway: A New Class of DNA Payloads

cssDNA represents a shift in thinking. The next generation of gene therapy will be built not just on better tools—but on better molecular formats. By addressing the limitations of dsDNA while enabling large, complex edits, cssDNA is emerging as a core platform for future genetic medicine.

Subscribe to our blog

ABOUT THE AUTHOR

Tyler Kozisek

Tyler Kozisek, PhD, is a senior scientist in Aldevron's R&D area. He holds a Bachelor of Science in Mechanical Engineering and a PhD in Bioengineering and Biomedical Engineering, both from the University of Nebraska-Lincoln.